Artigo Revisado por pares

Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period

2016; Elsevier BV; Linguagem: Inglês

10.1183/13993003.congress-2016.oa4828

ISSN

1873-281X

Autores

Arkadiy Khanin, И. Б. Викторова, Sergey Dolgikh, Irina Garavskaya,

Tópico(s)

HIV, TB, and STIs Epidemiology

Resumo

The aim of the study was to estimate the dynamics of primary drug resistance in a big industrial city of Western Siberia with high burden of TB (incidence is about 100/100 000) and HIV (prevalence is 1320/100 0000) with proportion of HIV-positive patients among new TB cases about 33% (2014). Materials and methods: the results of drug susceptibility tests (DST) to I line anti-TB drugs among new TB cases of civil sector were studied over 10 years period (2004-2014). In 2004 (593 new TB cases, includig 65 cases of HIV/TB) DST to first line drugs was conducted in 304 (82,8%) of 367 culture positive cases; in 2014 (542 new cases, including 183 cases of TB/HIV) DST to first line drugs was conducted in 210 (75,3%) of 279 culture positive new cases. DST were performed on Löwenstein-Jensen media using absolute concentration method. Results: resitance to at least one I line drug was found in 52% (n=159) in 2004, and 56,9% (n=118) in 2014. Any resistance with H+/-SE was found in 42,5% (n=129) in 2004, and decreased to 15,71% (n=33) in 2014. The level of primary MDR increased from 18,8% (n=57) in 2004 to 32,4% (n=64) in 2014 without a single case of primary XDR TB. Conclusion: primary MDR was detected in every third new TB patient in Novokuznetsk in 2014. Steady increase of primary MDR nearly 2 times (from 17,8 to 32,4%) for a ten years period signals the urgent need to revise the TB care concept.

Referência(s)
Altmetric
PlumX